Chimeric Therapeutics Limited Common Stock

Chimeric Therapeutics Limited (CHMMF) currently reports a common stock of $80M as of June 2026. That compares with $70M in the prior-year period — up 14.6% year over year. Use the charts on this page to explore Chimeric Therapeutics Limited's common stock history and peer comparisons.

Chimeric Therapeutics Limited's common stock increased from $70M to $80M — a 14.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Chimeric Therapeutics Limited reported $80M in common stock as of June 2026. That compares with $70M in the prior-year period — up 14.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $80M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Chimeric Therapeutics Limited, and consider following CHMMF for alerts when major investors trade the stock.

Chimeric Therapeutics Limited is classified in the Healthcare sector. On common stock, it currently shows $80M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CHMMF with unrelated industries.